Clinical and neuroimaging profiles to identify C9ORF72‐FTD patients and serum Neurofilament to monitor the progression and the severity of the disease.
…humans. AIM To identify clinical, neuroimaging, and biological features that could be used to identify FTD subjects eligible to genetic testing. METHODS This is a retrospective, case‐control study of clinical,…
read more